OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $215,000 | -66.4% | 382,286 | +2.7% | 0.00% | -100.0% |
| Q4 2015 | $640,000 | -18.4% | 372,324 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $784,000 | -57.0% | 371,646 | +0.8% | 0.00% | -50.0% |
| Q2 2015 | $1,825,000 | -34.8% | 368,690 | +3.1% | 0.00% | -50.0% |
| Q1 2015 | $2,800,000 | +30.6% | 357,607 | +1.1% | 0.00% | +33.3% |
| Q4 2014 | $2,144,000 | +40.3% | 353,763 | -1.4% | 0.00% | +50.0% |
| Q3 2014 | $1,528,000 | -26.4% | 358,731 | +6.8% | 0.00% | -33.3% |
| Q2 2014 | $2,075,000 | +3.9% | 335,836 | +9.3% | 0.00% | 0.0% |
| Q1 2014 | $1,997,000 | +28.1% | 307,207 | +11.0% | 0.00% | +50.0% |
| Q4 2013 | $1,559,000 | -5.5% | 276,862 | +2.9% | 0.00% | -33.3% |
| Q3 2013 | $1,649,000 | +12.9% | 268,976 | +7.6% | 0.00% | 0.0% |
| Q2 2013 | $1,461,000 | – | 249,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |